Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Desrosiers, Martin" or (type any "bookEditor issueEditor" and editor="Desrosiers, Martin")

Add to list
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Joaquim Mullol, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter W Hellings, Joseph K Han, Roger Jankowski, Jan Vodicka, Philippe Gevaert (UGent) , Nadia Daizadeh, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(4). p.1086-1095.e5
Add to list
- Journal Article
- A1
- open access
Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

G Walter Canonica, Arnaud Bourdin, Anju T Peters, Martin Desrosiers, Claus Bachert (UGent) , Stephan Weidinger, Eric L Simpson, Nadia Daizadeh, Zhen Chen, Siddesh Kamat, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(6). p.1515-1526
Add to list
- Journal Article
- A1
- open access
Reducing fungal exposure critical for treating rhinosinusitis with or without polyps [response to letter]

Claus Bachert (UGent) , Neil Bhattacharyya, Martin Desrosiers and Asif H. Khan (UGent)

(2021) JOURNAL OF ASTHMA AND ALLERGY. 14. p.393-395
Add to list
- Journal Article
- A1
- open access
Burden of disease in chronic rhinosinusitis with nasal polyps

Claus Bachert (UGent) , Neil Bhattacharyya, Martin Desrosiers and Asif H. Khan

(2021) JOURNAL OF ASTHMA AND ALLERGY. 14. p.127-134
Add to list
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

Claire Hopkins, Martin Wagenmann, Claus Bachert (UGent) , Martin Desrosiers, Joseph K. Han, Peter W. Hellings, Stella E. Lee, Jerome Msihid, Amr Radwan, Paul Rowe, et al.

(2021) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 11(7). p.1087-1101
Add to list
- Journal Article
- A1
- open access
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

Tanya M. Laidlaw, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter Hellings (UGent) , Joaquim Mullol, Jorge F. Maspero, Philippe Gevaert (UGent) , Mei Zhang, Xuezhou Mao, et al.

(2021) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 126(5). p.584-592.e1
Add to list
International consensus statement on allergy and rhinology : rhinosinusitis 2021

Richard R. Orlandi, Todd T. Kingdom, Timothy L. Smith, Benjamin Bleier, Adam DeConde, Amber U. Luong, David M. Poetker, Zachary Soler, Kevin C. Welch, Sarah K. Wise, et al.

(2021) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 11(3). p.213-739
Add to list
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE) : a randomised, double-blind, placebo-controlled, phase 3 trial

Joseph K Han, Claus Bachert (UGent) , Wytske Fokkens, Martin Desrosiers, Martin Wagenmann, Stella E Lee, Steven G Smith, Neil Martin, Bhabita Mayer, Steven W Yancey, et al.

(2021) LANCET RESPIRATORY MEDICINE. 9(10). p.1141-1153
Add to list
Late breaking abstract : add-on mepolizumab for chronic rhinosinusitis with nasal polyps : SYNAPSE study

Claire Hopkins, Claus Bachert (UGent) , Wytske Fokkens, Martin Desrosiers, Martin Wagenmann, Stella Lee, Ana Sousa, Steven Smith, Neil Martin, Bhabita Mayer, et al.

(2020) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 56(64).
Add to list
Efficacy and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps : results from the randomized phase 3 sinus-24 study

Joseph K Han, Claus Bachert (UGent) , Martin Desrosiers, Tanya M Laidlaw, Claire Hopkins, Wytske J Fokkens, Pierluigi Paggiaro, Seong Ho Cho, Heidi Olze, Leon S Greos, et al.

(2019) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 143(2, suppl.). p.AB422-AB422

Academic Bibliography

Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

Reducing fungal exposure critical for treating rhinosinusitis with or without polyps [response to letter]

Burden of disease in chronic rhinosinusitis with nasal polyps

Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

International consensus statement on allergy and rhinology : rhinosinusitis 2021

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE) : a randomised, double-blind, placebo-controlled, phase 3 trial

Late breaking abstract : add-on mepolizumab for chronic rhinosinusitis with nasal polyps : SYNAPSE study

Efficacy and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps : results from the randomized phase 3 sinus-24 study

Contents

Support

Contact